Swelling and loss of photoreceptors in chronic human and experimental glaucomas

Archives of Ophthalmology

Volumn 118, Issue 2, 2000, Pages 235-245

  Nork, T Michael ^a   Ver Hoeve, James N ^a   Poulsen, Gretchen L ^a   Nickells, Robert W ^a   Davis, Matthew D ^a   Weber, Arthur J ^b   Vaegan, ^c   Sarks, Shirley H ^d   Lemley, Heath L ^e   Millecchia, Lyndell L ^e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Eye and Vision Research Institute   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL VOLUME; COLOR VISION DEFECT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; NONHUMAN; OPEN ANGLE GLAUCOMA; PHOTORECEPTOR; PRIORITY JOURNAL; RECEPTOR DENSITY; RHESUS MONKEY;

EID: 18544405639     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.2.235     Document Type: Article

References (78)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996; 80:389-393.
2. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
3. Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol. 1969;53:721-748.
4. Ouigley HA, Green WR. The histology of human glaucoma cupping and nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology. 1979;10:1803-1827.
5. Alvis DL. Electroretinographic changes in controlled chronic open-angle glaucoma. Am J Ophthalmol. 1966;61:121-131.
6. Fazio DT, Heckenlively JR, Martin DA, Christensen RE. The electroretinogram in advanced open-angle glaucoma. Doc Ophthalmol. 1986;63:45-54.
7. Holopigian K, Seiple W, Mayron C, Koty R, Lorenzo M. Electrophysiological and psychophysical flicker sensitivity in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 1990;31:1863-1868.
8. Odom JV, Feghali JG, Jin JC, Weinstein GW. Visual function deficits in glaucoma: electroretinogram pattern and luminance nonlinearities. Arch Ophthalmol. 1990;108:222-227.
9. Vaegan, Graham SL, Goldberg I, Buckland L, Hollows FC. Flash and pattern electroretinogram changes with optic atrophy and glaucoma. Exp Eye Res. 1995;60: 697-706.
10. Weiner A, Ripkin DJ, Patel S, Kaufman SR, Kohn HD, Weidenthal DT. Foveal dysfunction and central visual field loss in glaucoma. Arch Ophthalmol. 1998;116: 1169-1174.
11. Frishman LJ, Shen FF, Du L. et al. The scotopic electroretinogram of macaque after retinal ganglion cell loss from experimental glaucoma. Invest Ophthalmol Vis Sci. 1996;37:125-141.
12. Pokorny J, Smith VC. Eye disease and color defects. Vision Res. 1986;26:1573-1584.
13. Nork TM, Millecchia LL, Strickland BD, Linberg JV, Chao GM. Selective loss of blue cones and rods in human retinal detachment. Arch Ophthalmol. 1995;113: 1066-1073.
14. Nork TM, Cho NC, Poulsen GL. Selective loss of blue cones in human diabetic retinopathy [ARVO abstract]. Invest Ophthalmol Vis Sci. 1999;40:S306. Abstract 1618.
15. François J, Verriest G. Les dyschromatopsies acquises dans le glaucome primaire. Ann Oculistique. 1959;192:191-199.
16. Grutzner P, Schleicher S. Acquired color vision defects in glaucoma patients. Mod Probl Ophthalmol. 1972;11136-140.
17. Fishman GA, Krill AE, Fishman M. Acquired color vision defects in patients with open-angle glaucoma and ocular hypertension. Mod Probl Ophthalmol. 1974; 13:335-338.
18. Lakowski R, Drance SM. Acquired dyschromatopsias: the earliest functional losses in glaucoma. Doc Ophthalmol Proc Ser. 1979;19:159-165.
19. Poinoosawmy D, Nagasubramanian S, Gloster J. Color vision in patients with chronic simple glaucoma and ocular hypertension. Br J Ophthalmol. 1980;64: 852-857.
20. Anderson DR, Davis EB. Sensitivities of ocular tissues to acute pressure-induced ischemia. Arch Ophthalmol. 1975;93:267-274.
21. Büchi ER. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study, I: ganglion cell layer and inner nuclear layer. Exp Eye Res. 1992;55:605-613.
22. Büchi ER. Cell death in rat retina after pressure-induced ischaemia-reperfusion insult: electron microscopic study, II: outer nuclear layer. Jpn J Ophthalmol. 1992; 36:62-68.
23. Panda S, Jonas JB. Decreased photoreceptor count in human eyes with secondary angle-closure glaucoma. Invest Ophthalmol Vis Sci. 1992;33:2532-2536.
24. Janssen P, Naskar R, Moore S, Thanos S, Thiel HJ. Evidence for glaucoma-induced horizontal cell alterations in the human retina. Ger J Ophthalmol. 1997; 5:378-385.
25. Kendell KR, Quigley HA, Kerrigan LA, Pease ME, Quigley EN. Primary open-angle glaucoma is not associated with photoreceptor loss. Invest Ophthalmol Vis Sci. 1995;36:200-205.
26. Wygnanski T, Desatnik H, Quigley HA, Glovinsky Y. Comparison of ganglion cell loss and cone loss in experimental glaucoma. Am J Ophthalmol. 1995;120:184-189.
27. Nork TM, McCormick SA, Chao GM, Odom JV. Distribution of carbonic anhydrase among human photoreceptors. Invest Ophthalmol Vis Sci. 1990;31:1451-1458.
28. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: The Baltimore Eye Survey. JAMA. 1991;266:369-374.
29. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: The Baltimore Eye Survey. Am J Epidemiol. 1991;134:1102-1110.
30. Hart WM Jr, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology. 1982;89:268-279.
31. Phelps CD, Hayreh SS, Montague PR. Visual fields in low-tension glaucoma, primary open angle glaucoma, and anterior ischemic optic neuropathy. In: Greve EL, Heijl A, eds. Fifth International Visual Field Symposium. The Hague, the Netherlands: Dr W Junk; 1983:113-124.
32. Heijl A, Lundqvist L. The frequency distribution of earliest glaucomatous visual field defects documented by automatic perimetry. Acta Ophthalmol. 1984;62: 658-664.
33. Drance SM. Glaucomatous visual field defects. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. St Louis, Mo: CV Mosby Co; 1989:393-402.
34. Quigley HA, Hohman RM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci. 1983;24:1305-1307.
35. Pederson JE, Gaasterland DE. Laser-induced primate glaucoma, I: progression of cupping. Arch Ophthalmol. 1984;102:1689-1692.
36. Peterson JA, Kiland JA, Croft MA, Kaufman PL. Intraocular pressure measurement in cynomolgus monkeys: Tono-Pen versus manometry. Invest Ophthalmol Vis Sci. 1996;37:1197-1199.
37. Ahnelt PK, Kolb H, Pflug R. Identification of a subtype of cone photoreceptor, likely to be blue sensitive, in the human retina. J Comp Neurol. 1987;255:18-34.
38. Cohen JA. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
39. Marc RE, Sperling HG. Chromatic organization of primate cones. Science. 1977; 196:454-456.
40. Sperling HG, Johnson C, Harwerth RS. Differential spectral photic damage to primate cones. Vision Res. 1980;20:1117-1125.
41. de Monasterio FM, Schein SJ, McCrane EP. Staining of blue-sensitive cones of the macaque retina by a fluorescent dye. Science. 1981;213:1278-1281.
42. McCrane EP, de Monasterio FM, Schein SJ, Caruso RC. Non-fluorescent dye staining of primate blue cones. Invest Ophthalmol Vis Sci. 1983;24:1449-1455.
43. Szél A, Diamantstein T, Rohlich P. Identification of the blue-sensitive cones in the mammalian retina by anti-visual pigment antibody. J Comp Neurol. 1988; 273:593-602.
44. Gao H, Hollyfield JG. Aging of the human retina: differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:1-17.
45. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34:3278-3296.
46. Quigley HA, Addicks EM, Green RW. Optic nerve damage in human glaucoma, III: quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Ophthalmology. 1982;100:135-146.
47. Radius RL, Pederson JE. Laser-induced primate glaucoma, II: histopathology. Arch Ophthalmol. 1984;102:1693-1698.
48. Harwerth RS, Smith EL, Desantis L. Experimental glaucoma: perimetric field defects and intraocular pressure. J Glaucoma. 1997;6:390-401.
49. Alm A, Bill A. Blood flow and oxygen extraction in the cat uvea at normal and high intraocular pressures. Acta Physiol Scand. 1970;80:19-28.
50. Yancey CM, Linsenmeier RA. Oxygen distribution and consumption in the cat retina at increased intraocular pressure. Invest Ophthalmol Vis Sci. 1989;30: 600-611.
51. 2 in the cat during elevated intraocular pressure. Invest Ophthalmol Vis Sci. 1988;29:700-707.
52. Rojanapongpun P, Drance SM, Morrison BJ. Ophthalmic artery flow velocity in glaucomatous and normal subjects. Br J Ophthalmol. 1993;77:25-29.
53. Michelson G, Groh MJ, Groh ME, Grundler A. Advanced primary open-angle glaucoma is associated with decreased ophthalmic artery blood-flow velocity. Ger J Ophthalmol. 1995;4:21-24.
54. Cellini M, Possati GL, Caramazza N, Caramazza R. Colour Doppler analysis of the choroidal circulation in chronic open-angle glaucoma. Ophthalmologica. 1996; 210:200-202.
55. Yamazaki Y, Drance SM. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol. 1997;124:287-295.
56. Butt Z, O'Brien C, McKillop G, Aspinall P, Allan P. Color Doppler imaging in untreated high- and normal-pressure open-angle glaucoma. Invest Ophthalmol Vis Sci. 1997;38:690-696.
57. Kaiser HJ, Schoetzau A, Stumpfig D, Flammer J. Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma. Am J Ophthalmol. 1997;123:320-327.
58. Yin ZQ, Vaegan, Millar TJ, Beaumont P, Sarks S. Widespread choroidal insufficiency in primary open-angle glaucoma. J Glaucoma. 1997;6:23-32.
59. Nork TM, Wang LP, Poulsen GL. Selective loss of photoreceptors in human diabetic retinopathy [ARVO abstract]. Invest Ophthalmol Vis Sci. 1994;35:S1588. Abstract 1537.
60. Greenstein VC, Hood DC, Ritch R, Steinberger D, Carr RE. S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci. 1989;30:1732-1737.
61. Greenstein VC, Shapiro A, Hood DC, Zaidi Q. Chromatic and luminance sensitivity in diabetes and glaucoma. J Opt Soc Am A. 1993;10:1785-1791.
62. Ogiso M. Examination of confusion loci in acquired color vision deficiency with surface color. Nippon Ganka Gakkai Zasshi. 1993;97:411-418.
63. Greenstein VC, Halevy D, Zaidi Q, Koenig KL, Ritch RH. Chromatic and luminance systems deficits in glaucoma. Vision Res. 1996;36:621-629.
64. Kalloniatis M, Harwerth RS, Smith EL, DeSantis L. Colour vision anomalies following experimental glaucoma in monkeys. Ophthalmic Physiol Opt. 1993;13:56-67.
65. Nathans J, Thomas D, Hogness DS. Molecular genetics of human color vision: the genes encoding blue, green and red pigments. Science. 1986;232:193-202.
66. Röhrenbeck J, Wässle H, Boycott BB. Horizontal cells in the monkey retina: immunocytochemical staining with antibodies against calcium binding proteins. Eur J Neurosci. 1989;1:407-420.
67. Nork TM, Mangini NJ, Millecchia LL. Rods and cones contain antigenically distinctive S-antigens. Invest Ophthalmol Vis Sci. 1993;34:2918-2925.
68. Röhlich P, Szel A, Johnson LV, Hageman GS. Carbohydrate components recognized by the cone-specific monoclonal antibody CSA-1 and by peanut agglutinin are associated with red- and green-sensitive cone photoreceptors. J Comp Neurol. 1989;289:395-400.
69. Wallow IH. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol. 1984;102:126-135.
70. Wallow IH, Sponsel WE, Stevens TS. Clinicopathologic correlation of diode laser burns in monkeys. Arch Ophthalmol. 1991;109:648-653.
71. Stone JL, Barlow WE, Humayun MS, de Juan E Jr, Milam AH. Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa. Arch Ophthalmol. 1992;110:1634-1639.
72. Eisenfeld AJ, LaVail MM, LaVail JH. Assessment of possible transneuronal changes in the retina of rats with inherited retinal dystrophy: cell size, number, synapses, and axonal transport by retinal ganglion cells. J Comp Neurol. 1984;223:22-34.
73. Hartveit E, Brandstatter JH, Sassoe-Pognetto M, Laurie DJ, Seeburg PH, Wassle H. Localization and developmental expression of the NMDA receptor subunit NR2A in the mammalian retina. J Comp Neurol. 1994;348:570-582.
74. Brandstatter JH, Hartveit E, Sassoe-Pognetto M, Wassle H. Expression of NMDA and high-aftinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci. 1994;6:1100-1112.
75. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992;8:567-573.
76. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
77. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest Ophthalmol Vis Sci. 1996;37:1618-1624.
78. Massey SC. Cell types using glutamate as a neurotransmitter in the vertebrate retina. Prog Retin Res. 1990;9:399-425.